A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1255-1258

  Montanelli, Lucia ^a,c   Delbaere, Anne ^b   Di Carlo, Costantino ^d   Nappi, Carmine ^d   Smits, Guillaume ^a,b   Vassart, Gilbert ^a,b,e   Costagliola, Sabine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e IRIBHM   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHORIONIC GONADOTROPIN; DNA; FOLLITROPIN RECEPTOR; THREONINE; THYROTROPIN; CYCLIC AMP;

ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CODON; CONSERVATIVE TREATMENT; DNA SEQUENCE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GESTATIONAL AGE; HETEROZYGOSITY; HUMAN; LABORATORY TEST; OVARY DISEASE; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; STIMULATION; ANIMAL; COS 1 CELL LINE; GENETIC TRANSFECTION; GENETICS; METABOLISM; OVARY HYPERSTIMULATION; POINT MUTATION;

ADULT; ANIMALS; COS CELLS; CYCLIC AMP; FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; POINT MUTATION; PREGNANCY; RECEPTORS, FSH; RECURRENCE; SEQUENCE ANALYSIS, DNA; TRANSFECTION;

FALLOPIA;

EID: 1642294189     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031910     Document Type: Article

References (27)

1. Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. Hum Reprod 1997; 12(6):1129-1137.
2. Schenker JG. Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 1999; 85(1):13-20.
3. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002; 8(6):559-577.
4. Vasseur C, Rodien P, Beau I et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003; 349(8):753-759.
5. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 2003; 349(8):760-766.
6. Ludwig M, Gembruch U, Bauer O, Diedrich K. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum Reprod 1998; 13(8):2082-2087.
7. Di Carlo C, Bruno P, Cirillo D, Morgera R, Pellicano M, Nappi C. Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome. Hum Reprod 1997; 12(10):2115-2117.
8. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44(6):430-440.
9. Gromoll J, Brocker M, Derwahl M, Hoppner W. Detection of mutations in glycoprotein hormone receptors. Methods 2000; 21(1):83-97.
10. Smits G, Campillo M, Govaerts C et al. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 2003; 22(11):2692-2703.
11. Ballesteros JA, Weinstein H. Receptor Molecular Biology Methods in Neurosciences 1995; 25:333-428.
12. Dias JA, Cohen BD, Lindau-Shepard B, Nechamen CA, Peterson AJ, Schmidt A. Molecular, structural, and cellular biology of follitropin and follitropin receptor. Vitam Horm 2002; 64:249-322.:249-322.
13. Kudo M, Osuga Y, Kobilka BK, Hsueh AJW. Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop. J Biol Chem 1996; 271(37):22470-22478.
14. Gromoll J, Simoni M, Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 1996; 81(4):1367-1370.
15. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000; 21(5):551-583.
16. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18(3):404-433.
17. Schubert RL, Narayan P, Puett D. Specificity of Cognate Ligand-Receptor Interactions: Fusion Proteins of Human Chorionic Gonadotropin and the Heptahelical Receptors for Human Luteinizing Hormone, Thyroid-Stimulating Hormone, and Follicle-Stimulating Hormone. Endocrinology 2003; 144(1):129-137.
18. Rotmensch S, Scommegna A. Spontaneous ovarian hyperstimulation syndrome associated with hypothyroidism. Am J Obstet Gynecol 1989; 160(5 Pt 1):1220-1222.
19. Nagayama Y, Yamasaki H, Takeshita A et al. Thyrotropin binding specificity for the thyrotropin receptor. J Endocrinol Invest 1995; 18(4):283-287.
20. Rodien P, Bremont C, Sanson ML et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998; 339(25):1823-1826.
21. Moyle WR, Campbell RK, Rao SN et al. Model of human chorionic gonadotropin and lutropin receptor interaction that explains signal transduction of the glycoprotein hormones. J Biol Chem 1995; 270(34):20020-20031.
22. Bhowmick N, Narayan P, Puett D. Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding. Endocrinology 1999; 140(10):4558-4563.
23. Nagayama Y, Russo D, Wadsworth HL, Chazenbalk GD, Rapoport B. Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J Biol Chem 1991; 266(23):14926-14930.
24. Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol Endocrinol 1996; 10(9):1147-1159.
25. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 2002; 16(4):736-746.
26. Gether U, Asmar F, Meinild AK, Rasmussen SG. Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol 2002; 91(6):304-312.
27. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993; 268(7):4625-4636.